Stoke Therapeutics (STOK) Competitor Comparison
We are evaluating the key criteria listed to compare Stoke Therapeutics (STOK) against its competitors in the Biotechnology industry.
Market Capitalization
188 / 368Gross Profits
97 / 278Total Revenue
187 / 300EBITDA
216 / 337Free Cashflow
214 / 352Quick Ratio
98 / 357Earnings per Share
215 / 359Dividend yield
0 / 6Total Cash
150 / 358Performance 3 years
184 / 368Performance 5 years
175 / 368Performance 10 years
157 / 368Linearity 3 years
136 / 368Linearity 5 years
99 / 368Linearity 10 years
88 / 368Total Rank
268 / 368Dividend Rank
277 / 368Valuation Rank
94 / 368Piotroski Rank
210 / 368Muliplier Rank
211 / 368EBITDA - STOK ranking 216 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.